Narayanan developing treatments for alphaviruses
Aarthi Narayanan, Professor, Biology, received funding for the project: "Further the development of Omaveloxolone and Bardoxolone methyl as broadly effective countermeasures against alphaviruses to Support the Battelle Accelerated Therapeutics for Combating Acute Viral Epidemics (BAT-CAVE) Program."
The principal purpose of this program is to conduct Research and Development into medical, pharmaceutical, and diagnostic technologies to enhance mission effectiveness of military personnel, collaborating ...







